Kintec-solution GMBH
USPTO PatentsView assignee record - 7 granted patents across 4 technology areas, recorded in grant years 2015–2017. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A47C (CHAIRS; SOFAS; Beds).
The verdict
According to USPTO PatentsView, Kintec-solution ranks #36,127 of 49,997 tracked US assignees by granted-patent volume, with 7 patents across 4 technology areas.
- #36,127
- of 49,997 US assignees by volume
- 13th percentile
- by Innovation Score (23.6/100)
- 15.6
- avg claims per patent
- -100%
- grant velocity, last 5 yrs
USPTO PatentsView assignee plate
Corpus R36127 · Foreign Corporation #36,127 · 7 grants
GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-FRNCORP · VEL-DROP · BOOK-FULL
- GRANTS-MICRO 7 grants
- MID-PACK #36,127/49,997
- PHOTO-FINISH Kibow Biotech
- CPC-NARROW A47C · 4 areas
- INNOV-THIN 23.6/100
- CLAIMS-RICH 15.6 claims/avg
- TYPE-FRNCORP Foreign Corp
- VEL-DROP -100% vel
- BOOK-FULL 10/10 fields
Nearest grant-volume peer: Kibow Biotech Inc. (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
How Kintec-solution’s 23.6 Innovation Score adds up
The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.
Innovation-score neighbourhood around Kintec-solution
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
- Qualcomm Incorporated · highest
Qualcomm Incorporated · highest
85 score
- Kintec-solution · this assignee 24
Kintec-solution · this assignee
24 score
- 3D Lighting… · lowest 7
3D Lighting… · lowest
7 score
What this shows Kintec-solution's Innovation Score is 23.6/100 (13th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Does more volume mean deeper claims for Kintec-solution?
Each dot is one of Kintec-solution’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Kintec-solution’s own 15.6 claims/patent is ABOVE the 6.4 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.
Where Kintec-solution's grants concentrate
Kintec-solution GMBH is a focused PatentsView assignee: 4 CPC subclasses with 100% of grants classified under A47C (CHAIRS; SOFAS; Beds). Peak complete grant year is 2017 (3 grants) versus a trough of 2 in 2015. By volume, Kintec-solution sits between Kibow Biotech Inc. and Klueber Lubrication Muenchen SE & Co. KG.
Who files at Kintec-solution's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- Kibow Biotech
Kibow Biotech Inc.
7 patents
- Kietta
Kietta
7 patents
- Kimberbell Kids L…
Kimberbell Kids, L.L.C.
7 patents
- Kinetrol
Kinetrol Limited
7 patents
- Kinto
Kinto Co., Ltd.
7 patents
- Kira
Kira Inc.
7 patents
- Kirk Wrench
Kirk Wrench LLC
7 patents
- Klueber Lubricati…
Klueber Lubrication Muenchen SE & Co. KG
7 patents
- Kintec-solution ◀
Kintec-solution GMBH
7 patents
What this shows Kintec-solution holds 7 patents at rank #36,087, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near Kintec-solution
By rank, the assignees closest to #36,087 in granted patent volume.
- Kibow Biotech Inc. #36,083 · 7 patents
- Kietta #36,084 · 7 patents
- Kimberbell Kids, L.L.C. #36,085 · 7 patents
- Kinetrol Limited #36,086 · 7 patents
- Kinto Co., Ltd. #36,088 · 7 patents
- Kira Inc. #36,089 · 7 patents
- Kirk Wrench LLC #36,090 · 7 patents
- Klueber Lubrication Muenchen SE & Co. KG #36,091 · 7 patents
Leaders in A47C (Chairs)
Other assignees with the most granted patents in Kintec-solution's primary technology class.
Kintec-solution's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
24 13th percentile higher than 13% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 2 | 28.6% |
| 2016 | 2 | 28.6% |
| 2017 | 3 | 42.9% |
Which technologies does Kintec-solution GMBH patent most?
Top 4 of 4 technology areas
Data Source
USPTO PatentsView, US granted patents 2015–2025
What to do with this data
Kintec-solution GMBH's patent record in context - here's where to go next.
- Kintec-solution GMBH's lead technology class is A47C (CHAIRS; SOFAS; Beds), 100% of its portfolio - see every assignee active in that class. Explore A47C
- Ranked #36,127 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
- Compare Kintec-solution GMBH against Kibow Biotech Inc., an assignee filing at a similar volume. Compare portfolios
- Innovation Score of 23.6/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.